Your Notifications
All done, no notifications

What is a Follicular Lymphoma?

Follicular lymphoma is a type of B-cell non-Hodgkin lymphoma that develops from abnormal B lymphocytes, a type of white blood cell involved in the immune system. It is generally considered an indolent, or slow-growing, lymphoma, although its behaviour can vary between individuals. Follicular lymphoma commonly affects lymph nodes but can also involve the bone marrow, spleen, and other tissues.

What is the Importance of Timely Treatment?

Timely diagnosis and appropriate management can help determine the extent and biological characteristics of follicular lymphoma and guide treatment decisions. Because many cases grow slowly, immediate treatment is not always necessary. Some patients with asymptomatic, low-burden disease may be monitored through active surveillance, or watchful waiting.

What are the Common Symptoms of Follicular Lymphoma?

  • Painless swelling of lymph nodes in the neck, armpit, or groin
  • Persistent fatigue or weakness
  • Unexplained weight loss
  • Fever without an obvious infection
  • Drenching night sweats
  • Abdominal discomfort or fullness due to an enlarged spleen or lymph nodes
  • Recurrent infections in some patients
  • Shortness of breath or other symptoms when enlarged lymph nodes affect nearby structures

Causes and Risk Factors of Follicular Lymphoma

Causes

  • The exact cause of follicular lymphoma is not fully understood. It develops when genetic changes in B lymphocytes cause them to grow or survive abnormally.
  • A characteristic genetic change involving the BCL2 gene on chromosome 18 is commonly associated with follicular lymphoma, although this change alone does not necessarily cause lymphoma.

Risk Factors

  • Increasing age
  • Certain abnormalities of the immune system
  • Immunosuppressive conditions or treatments
  • Some autoimmune diseases
  • Certain infections or environmental exposures may be associated with lymphoma risk, although their specific role in follicular lymphoma varies

Latest Research and Technologies in the Treatment of Follicular Lymphoma in Singapore

  • Advances in follicular lymphoma treatment include newer immunotherapies, such as bispecific antibodies and CAR-T cell therapy, for selected patients whose disease has relapsed or not responded to previous treatments. Improved pathological and molecular testing also helps specialists characterise the lymphoma and guide treatment decisions.

Treatment options for Follicular Lymphoma

Immunotherapy : Anti-CD20 antibodies may be used alone or in combination with other treatments.

Chemoimmunotherapy: Chemotherapy combined with an antibody may be considered for patients who require systemic treatment.

Targeted therapy : Targeted medicines may be considered in selected relapsed or refractory cases.

CAR-T cell therapy : For selected patients with relapsed or refractory follicular lymphoma after previous systemic treatments, CAR-T therapy may be considered at specialised centres.

Stem cell transplantation : Autologous stem cell transplantation may be considered in selected patients with relapsed or refractory disease, although its use depends on the clinical situation and availability of newer therapies.

Cost Start From 39000Explore Options

  • Clinical assessment:
    • Detailed medical history and physical examination: including assessment of enlarged lymph nodes, spleen, and other symptoms. Blood tests may evaluate blood cell counts, kidney and liver function, and other relevant markers.
    • Tissue biopsy: An excisional or core lymph-node biopsy is generally important to confirm the diagnosis and determine the lymphoma subtype and grade. Immunohistochemistry and other pathological tests help identify characteristic markers.
    • Bone marrow evaluation: Bone marrow testing may be considered in selected patients depending on the clinical situation and whether the results will influence staging or treatment.
  • Imaging Tests:
    • PET/CT scan: Helps assess where lymphoma is present in the body, supports staging in appropriate cases, and evaluates treatment response. It may also help identify areas that require further investigation when transformation into a more aggressive lymphoma is suspected.
    • CT scan: Can evaluate enlarged lymph nodes and involvement of organs such as the chest, abdomen, and pelvis.
    • MRI: May be used when detailed assessment of particular organs or anatomical areas is required.
    • Ultrasound: Can help evaluate superficial lymph nodes or abdominal organs in selected cases.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Follicular Lymphoma patients in Singapore. These services include:

  • Physical activity: Gradual activity can help maintain strength and endurance.
  • Physiotherapy: May help with weakness, reduced mobility, or treatment-related physical limitations.
  • Nutritional support: Helps maintain adequate calorie and protein intake during treatment.
  • Fatigue management: Structured activity, rest, sleep support, and energy conservation strategies can help manage cancer-related fatigue.
  • Psychological support: Counselling and supportive-care services may help patients cope with the emotional impact of diagnosis and treatment.
  • Treatment for follicular lymphoma depends on the disease stage, symptoms, tumor size, past treatments, and response to therapy. Options include antibody treatments, chemotherapy, immune-modulating drugs, targeted treatments, and other immune-based therapies. Some people can be monitored without treatment, while others need systemic therapy.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Follicular Lymphoma in Singapore

Farrer Park Hospital: Top Doctors, and Reviews
Farrer Park Hospital

Singapore, Singapore

Apart from in-detail treatment procedures available, Farrer Park Hospital located in Connexion, Singapore has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:

  • A medical centre is linked to the Farrer Park Hospital Complex, Connexion, Singapore
  • The focus of the hospital is to bring together two essential elements: those of healthcare combined with hospitality.
  • There is a building with 20 different stories which comprises Owen Link, hotel and spa.
  • Personal attention and patient care focus is maintained with a system in place of listening, analysing, evaluating and then implementing a treatment plan.
  • 121 bed capacity
  • Technology and innovations help provide the best of medical and surgical treatment options.
  • Professionally implemented international patient care systems
  • Suites: Cardiovascular, day surgery, endoscopy, major surgery, nuclear medicine, radiation oncology, and inpatient suite
  • Diagnostic imaging and intensive care unit
  • 24 hour emergency clinic and pharmacy
  • Facilities such as dialysis, nutrition services, rehab centre, and teaching clinic
Message Us

279

PROCEDURE

14

SPECIALITIES

7+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Singapore for Follicular Lymphoma Treatment?

  • Experienced hematologist-oncologists: Specialists experienced in lymphoma diagnosis, systemic therapy, and long-term disease management.
  • Advanced diagnostic facilities: PET/CT, immunohistochemistry, flow cytometry, cytogenetic and molecular testing can support accurate diagnosis and treatment planning.
  • Modern treatment options: Eligible patients may have access to immunotherapy, targeted treatments, bispecific antibodies, and cellular therapies at specialised centres.
  • Multidisciplinary care: Haematologists, oncologists, pathologists, radiologists, radiation oncologists, transplant specialists, and supportive-care teams can collaborate on complex cases.
  • International patient support: Many hospitals offer dedicated international patient services that can help with medical coordination, documentation, accommodation, travel arrangements, and follow-up planning.

Frequently Asked Questions

There is no fixed recovery period because follicular lymphoma is usually a chronic condition that may require long-term monitoring or treatment. Recovery after active treatment depends on the therapy used, disease response, side effects, and overall health.

Yes. Most people with follicular lymphoma can walk and stay physically active, especially when the disease isn't causing significant physical limitations. During treatment, you may need to adjust activity levels based on fatigue, blood counts, treatment effects, and medical advice.

Many specialised cancer centres in Singapore have access to advanced diagnostic and treatment technologies, including PET/CT, immunohistochemistry, molecular testing, immunotherapy, targeted therapies, and cellular therapies. Availability varies by hospital and by individual patient eligibility.

Many major Singaporean hospitals have dedicated international patient departments that assist with medical appointments, treatment coordination, travel documentation, accommodation, interpretation, and follow-up arrangements.

Consider a centre with experienced haematologist-oncologists, specialised lymphoma services, advanced pathology and imaging, access to appropriate systemic therapies, and multidisciplinary care. For relapsed or refractory disease, patients may also consider whether the centre provides cellular therapies such as CAR-T when clinically appropriate.

Follicular lymphoma outcomes vary by stage, tumour burden, disease biology, age, overall health, treatment received, and response to therapy. Follicular lymphoma is often responsive to treatment, but it can relapse and may require long-term monitoring. Patients should discuss their individual prognosis and treatment goals with their haematologist-oncologist rather than relying on a general success-rate figure.

Singapore has specialised haematology and oncology centres with doctors experienced in diagnosing and treating non-Hodgkin lymphomas, including follicular lymphoma. Experience and available treatments vary between institutions, so patients should review the specialist's lymphoma expertise and the hospital's treatment facilities.

Risks depend on the treatment used. Chemotherapy may cause fatigue, nausea, hair loss, low blood counts, and increased infection risk. Immunotherapy and targeted treatments can cause infusion reactions, immune-related effects, or other treatment-specific adverse effects. CAR-T therapy can cause complications such as cytokine release syndrome and neurological toxicities in some patients.

After a follicular lymphoma diagnosis, consult a haematologist-oncologist to review the biopsy results, lymphoma grade, stage, and overall health. Ask whether active surveillance or immediate treatment is appropriate, and discuss the benefits and risks of available options. A second pathology opinion may be useful if the diagnosis or lymphoma classification is uncertain.

Follicular lymphoma does not typically cause permanent physical deformities. However, advanced disease or treatment-related complications can sometimes affect physical function, depending on which organs or tissues are involved.

Yes. Symptoms such as fatigue, enlarged lymph nodes, night sweats, emotional stress, and treatment-related side effects can affect physical, social, and emotional well-being. Supportive care, symptom management, physical activity, nutrition, and psychological support can help address these concerns.

Some people with asymptomatic, low-tumour-burden follicular lymphoma can be safely managed with active surveillance, which involves regular clinical assessment and monitoring. However, the disease may progress over time and cause symptoms, organ involvement or other complications. In a small proportion of patients, it can transform into a more aggressive lymphoma, so new or worsening symptoms should be assessed promptly

Follicular lymphoma is more common in adults, particularly older adults, and occurs more frequently in some populations than others. The risk can also be influenced by immune-system disorders and certain other factors. Most people with these risk factors do not necessarily develop follicular lymphoma.

Author

Dr. Abdullah Rahil
Dr. Abdullah Rahil

MPT (Neuro)

7 Years of Experience

Dr. Abdullah Rahil, M.P.T. (Neurology), is a dedicated physiotherapy professional specializing in orthopedic, neurological, and musculoskeletal rehabilitation. With strong clinical expertise, he focuses on improving patient mobility, reducing pain, and restoring functional independence through evidence-based rehabilitation techniques. He is skilled in advanced therapeutic approaches that support effective rehabilitation and recovery for a wide range of musculoskeletal and neurological conditions, focusing on improving mobility, reducing pain, and restoring functional independence. Dr. Rahil has extensive experience managing diverse rehabilitation cases. His patient-centered approach emphasizes personalized treatment plans, continuous assessment, and comprehensive rehabilitation to achieve optimal recovery outcomes. View More

Reviewer

Dr. Mohit Agarwal
Dr. Mohit Agarwal

Medical Oncologist

14 Years of Experience

One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More

Last Reviewed - January 2026